• Online Features  This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Serum -Glutamyltransferase (GGT) and Thyroid Disease

Juan Jiménez-Alonso, MD; José Maria Rivera, MD; Rafael Muñoz, MD; Francisco Pérez-Jiménez, MD; Pedro Benito, MD; José Antonio; Jiménez-Perepérez, MD
Córdoba, Spain

Arch Intern Med. 1983;143(5):1070-1072.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—We read with interest the article by Azizi entitled "-Glutamyl Transpeptidase Levels in Thyroid Disease" in the January ARCHIVES (1982;142:79-81). We have studied the serum GGT activity in 24 patients with untreated thyroid diseases—12 with hyperthyroidism (ten female and two male patients, aged 26 to 80 years; mean ± SEM, 58.16 ± 5.23 years) and 12 with hypothyroidism (eight female and four male patients, aged 12 to 70 years; mean ± SEM, 52.66 ± 4.81 years). A group of eight female and four male normal volunteers served as control subjects. Their mean ± SEM age was 35.91 ± 1.92 years. The diagnosis of thyroid disease was based on clinical findings and measurement of serum free thyroxine (T₄) index and thyrotropin level. Serum GGT was assayed by a kinetic-spectrophotometric method according to Szasz.¹ None of the patients or control subjects with conditions known to modifier serum . . . [Full Text PDF of this Article]

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?